Professor Mark Molloy
People_

Professor Mark Molloy

PhD
Lawrence Penn Chair of Bowel Cancer Research
School of Medical Sciences
Faculty of Medicine and Health
Phone
9926 7870
Professor Mark Molloy

Mark completed his BSc(Hons) in the School of Biological Sciences at Macquarie University in 1995, then conducted his PhD research in the emerging field of proteomics with Professor Keith Williams in 2000. Mark moved to the USA for post-doctoral training in mass spectrometry with Professor Philip Andrews at the University of Michigan Medical School. Subsequently, Mark took a research scientist role in Pfizer Inc, using proteomics to discovery biomarkers of drug response and drug differentiation. Mark returned to Australia to take up an NHMRC Biomedical career development award to apply proteomics to investigate prognostic and predictive biomarkers associated with colorectal cancer. For this research he ustilised the proteomic infrastructure at the Australian Proteome Analysis Facility (APAF) at Macquarie University where he was appointed as Associate Professor. In 2010, Mark was appointed as APAF Director, leading a 20+ research team to apply proteomics in the life-sciences collaborating with academic and industry partners. Mark was interim Head of the Department of Chemistry and Biomolecular Sciences for 18 months until Feb 2017. In March 2018 he was selected as the inaugural Lawrence Penn Chair of Bowel Cancer Research at the Sydney Medical School, Northern Clinical School, RNSH campus.

Biomarkers, cancers, protein phosphorylation, mass spectrometry, proteomics, translational research, bowel cancer

Proteomic landscapes of bowel cancers subtypes

Molecular analysis of polyps and early stage bowel cancer development

Role of microbiota/microbiome in bowel cancer development and recurrence

Oncology drug response prediction using mass spectrometry

Australasian Proteomics Society (APS)

American Association Cancer Research (AACR)

American Society Mass Spectrometry (ASMS)

Human Proteome Organisation (HUPO)

American Society for Biochemistry and Molecular Biology (ASBMB)

Australian Gastrointestinal trials group (AGITG)

Cancer, Neurosciences and Mental Health
Project titleResearch student
Characterizing the Oral Microbiome Community Profile in Australian Head and Neck Squamous Cell Carcinoma PatientsHafiz Saad AHMAD

Publications

Book Chapters

  • Mirzaei, M., Pascovici, D., Wu, J., Chick, J., Wu, Y., Cooke, B., Haynes, P., Molloy, M. (2017). TMT one-stop shop: From reliable sample preparation to computational analysis platform. In Shivakumar Keerthikumar and Suresh Mathivanan (Eds.), Proteome Bioinformatics, (pp. 45-66). New York: Springer. [More Information]
  • Fung, D., Lo, A., Jankova, L., Clarke, S., Molloy, M., Robertson, G., Wilkins, M. (2011). Classification of Cancer Patients Using Pathway Analysis and Network Clustering. In Gerard Cagney, Andrew Emili (Eds.), Network Biology: Methods and Applications, (pp. 311-336). New York: Humana Press.

Journals

  • Zhu, H., Wright, B., Logel, D., Needham, P., Yehl, K., Molloy, M., Jaschke, P. (2024). IbpAB small heat shock proteins are not host factors for bacteriophage ϕX174 replication. Virology, 597, 110169. [More Information]
  • De Silva, M., Tse, B., Diakos, C., Clarke, S., Molloy, M. (2024). Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility. Cancer Immunology, Immunotherapy, 73(3), 53. [More Information]
  • Wong, G., Li, J., Mckay, M., Castaneda, M., Bhimani, N., Diakos, C., Hugh, T., Molloy, M. (2024). Proteogenomic Characterisation of Early Intrahepatic Recurrence After Curative-intent Treatment of Colorectal Liver Metastases. Journal of Proteome Research, 23(10), 4523-4537. [More Information]

Conferences

  • Pham, B., Molloy, M., Gamage, H., Emerson, M., Pham, T., Paulsen, I., Hawkett, B., Engel, A. (2021). Development of nanoparticles as biosensors for diagnosis of mucosa changes in situ during colonoscopy. Sydney Cancer Conference 2021, Australia: John Wiley & Sons. [More Information]
  • Wu, J., Breen, E., Song, X., Cooke, B., Molloy, M. (2013). A protein annotation framework empowered with semantic reasoning. 12th International Semantic Web Conference, ISWC 2013, Australia: CEUR-WS.

2024

  • Zhu, H., Wright, B., Logel, D., Needham, P., Yehl, K., Molloy, M., Jaschke, P. (2024). IbpAB small heat shock proteins are not host factors for bacteriophage ϕX174 replication. Virology, 597, 110169. [More Information]
  • De Silva, M., Tse, B., Diakos, C., Clarke, S., Molloy, M. (2024). Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility. Cancer Immunology, Immunotherapy, 73(3), 53. [More Information]
  • Wong, G., Li, J., Mckay, M., Castaneda, M., Bhimani, N., Diakos, C., Hugh, T., Molloy, M. (2024). Proteogenomic Characterisation of Early Intrahepatic Recurrence After Curative-intent Treatment of Colorectal Liver Metastases. Journal of Proteome Research, 23(10), 4523-4537. [More Information]

2023

  • Tse, B., Molloy, M., Bergamin, S., Steffen, P., Hruby, G., Pavlakis, N., Clarke, S., Evans, J., Engel, A., Kneebone, A. (2023). CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy. OncoImmunology, 12(1), 2238506. [More Information]
  • Welham, Z., Li, J., Engel, A., Molloy, M. (2023). Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing. Cancers, 15(20). [More Information]
  • O'Rourke, M., Januszewski, A., Sullivan, D., Lengyel, I., Stewart, A., Arya, S., Ma, R., Galande, S., Hardikar, A., Joglekar, M., Keech, A., Jenkins, A., Molloy, M. (2023). Optimised plasma sample preparation and LC-MS analysis to support large-scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial. Proteomics - Clinical Applications. [More Information]

2022

  • Li, J., Steffen, P., Tse, B., Seyed Ahadi, M., Gill, A., Engel, A., Molloy, M. (2022). Deep Sequencing of Early T Stage Colorectal Cancers Reveals Disruption of Homologous Recombination Repair in Microsatellite Stable Tumours with High Mutational Burdens. Cancers, 14(12). [More Information]
  • Rahman, M., Amirkhani, A., Parvin, F., Chowdhury, D., Molloy, M., Deva, A., Vickery, K., Hu, H. (2022). One Step Forward with Dry Surface Biofilm (DSB) of Staphylococcus aureus: TMT-Based Quantitative Proteomic Analysis Reveals Proteomic Shifts between DSB and Hydrated Biofilm. International Journal of Molecular Sciences, 23(20). [More Information]
  • Wright, B., Molloy, M., Jaschke, P. (2022). Overlapping genes in natural and engineered genomes. Nature Reviews Genetics, 23(3), 154-168. [More Information]

2021

  • O'Rourke, M., Sahni, S., Samra, J., Mittal, A., Molloy, M. (2021). Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma. Journal of Proteomics, 231, 1-8. [More Information]
  • Pham, B., Molloy, M., Gamage, H., Emerson, M., Pham, T., Paulsen, I., Hawkett, B., Engel, A. (2021). Development of nanoparticles as biosensors for diagnosis of mucosa changes in situ during colonoscopy. Sydney Cancer Conference 2021, Australia: John Wiley & Sons. [More Information]
  • Oh, B., Boyle, F., Pavlakis, N., Clarke, S., Guminski, A., Eade, T., Lamoury, G., Carroll, S., Morgia, M., Kneebone, A., Hruby, G., Stevens, M., Molloy, M., Back, M., et al (2021). Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review. Frontiers in Oncology, 11, 706331. [More Information]

2020

  • Gamage, H., Chong, R., Bucio-Noble, D., Kautto, L., Hardikar, A., Ball, M., Molloy, M., Packer, N., Paulsen, I. (2020). Changes in dietary fiber intake in mice reveal associations between colonic mucin O-glycosylation and specific gut bacteria. Gut Microbes, 12(1), 1802209. [More Information]
  • Voss, H., Wurlitzer, M., Smit, D., Ewald, F., Alawi, M., Spohn, M., Indenbirken, D., Omidi, M., David, K., Juhl, H., Molloy, M., et al (2020). Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer. Clinical and Experimental Metastasis, 37(6), 649-656. [More Information]
  • Piggin, C., Roden, D., Law, A., Molloy, M., Krisp, C., Swarbrick, A., Naylor, M., Kalyuga, M., Kaplan, W., Oakes, S., et al (2020). ELF5 modulates the estrogen receptor cistrome in breast cancer. PLoS Genetics, 16(1), 1-24. [More Information]

2019

  • Bhatnagar, A., McKay, M., Thaysen-Andersen, M., Arasaratnam, M., Crumbaker, M., Gurney, H., Molloy, M. (2019). Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and Delta(4)-abiraterone from cancer patients. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1126-1127, 1-9. [More Information]
  • Bucio-Noble, D., Semaan, C., Molloy, M. (2019). Examining cellular responses to kinase drug inhibition through phosphoproteome mapping of substrates. Methods in Molecular Biology, 1888, 141-152. [More Information]
  • Arasaratnam, M., Crumbaker, M., Bhatnagar, A., McKay, M., Molloy, M., Gurney, H. (2019). Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer. Cancer Chemotherapy and Pharmacology, 84(1), 139-146. [More Information]

2018

  • Bezawork-Geleta, A., Wen, H., Dong, L., Yan, B., Vider, J., Boukalova, S., Krobova, L., Vanova, K., Zobalova, R., Sobol, M., et al (2018). Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints. Nature Communications, 9(1). [More Information]
  • Lin, C., Krisp, C., Packer, N., Molloy, M. (2018). Development of a data independent acquisition mass spectrometry workflow to enable glycopeptide analysis without predefined glycan compositional knowledge. Journal of Proteomics, 172, 68-75. [More Information]
  • Gamage, H., Tetu, S., Chong, R., Bucio-Noble, D., Rosewarne, C., Kautto, L., Ball, M., Molloy, M., Packer, N., Paulsen, I. (2018). Fiber supplements derived from sugarcane stem, wheat dextrin and psyllium husk have different in vitro effects on the human gut microbiota. Frontiers in Microbiology, 9(Issue JUL), 1618. [More Information]

2017

  • Mirzaei, M., Gupta, V., Chick, J., Greco, T., Wu, Y., Chitranshi, N., Vander Wall, R., Hone, E., Deng, L., Dheer, Y., You, Y., Graham, S., et al (2017). Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Scientific Reports, 7(1), 1-16. [More Information]
  • Lee, A., Rayner, S., De Luca, A., Gwee, S., Morsch, M., Sundaramoorthy, V., Shahheydari, H., Ragagnin, A., Shi, B., Yang, S., et al (2017). Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF(cyclin F) complex. Open Biology, 7(10), 1-11. [More Information]
  • Hogan, A., Don, E., Rayner, S., Lee, A., Laird, A., Watchon, M., Winnick, C., Tarr, I., Morsch, M., Fifita, J., Nicholson, G., et al (2017). Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype. Human Molecular Genetics, 26(14), 2616-2626. [More Information]

2016

  • Kao, S., Kirschner, M., Cooper, W., Tran, T., Burgers, S., Wright, C., Korse, T., van den Broek, D., Edelman, J., Vallely, M., McCaughan, B., Pavlakis, N., Clarke, S., van Zandwijk, N., Reid, G., et al (2016). A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma. British Journal of Cancer, 114(5), 524-531. [More Information]
  • Song, X., Amirkhani, A., Wu, J., Pascovici, D., Zaw, T., Xavier, D., Clarke, S., Molloy, M. (2016). Analytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month period. Proteomics, 16(15-16), 2118-2127. [More Information]
  • Williams, K., Topp, S., Yang, S., Smith, B., Fifita, J., Warraich, S., Zhang, K., Farrawell, N., Vance, C., Dobson-Stone, C., Cole, N., Nicholson, G., et al (2016). CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nature Communications, 7, 1-8. [More Information]

2015

  • Martinez-Aguilar, J., Clifton-Bligh, R., Molloy, M. (2015). A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours. BMC Cancer, 15(1), 1-14. [More Information]
  • Pascovici, D., Song, X., Solomon, P., Winterberg, B., Mirzaei, M., Goodchild, A., Stanley, W., Liu, J., Molloy, M. (2015). Combining Protein Ratio p-Values as a Pragmatic Approach to the Analysis of Multirun iTRAQ Experiments. Journal of Proteome Research, 14(2), 738-746. [More Information]
  • Mahon, K., Lin, H., Castillo, L., Lee, B., Lee-Ng, K., Chatfield, M., Chiam, K., Breit, S., Brown, D., Molloy, M., Marx, G., Pavlakis, N., Boyer, M., Stockler, M., Horvath, L., et al (2015). Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. British Journal of Cancer, 112(8), 1340-1348. [More Information]

2014

  • Chik, J., Zhou, J., Moh, E., Christopherson, R., Clarke, S., Molloy, M., Packer, N. (2014). Comprehensive glycomics comparison between colon cancer cell cultures and tumours: Implications for biomarker studies. Journal of Proteomics, 108, 146-162. [More Information]
  • Alexander, K., Ly, L., McKay, M., Mallawaaratchy, D., Mactier, S., Crossett, B., Molloy, M., Buckland, M., McDonald, K., Christopherson, R. (2014). Comprehensive proteomic profiling of bevacizumab-resistant glioblastoma multiforme. Neuro-Oncology, 16(Suppl 2), ii98-ii98.
  • Hayes, S., Hudson, A., Clarke, S., Molloy, M., Howell, V. (2014). From mice to men: GEMMs as trial patients for new NSCLC therapies. Seminars in Cell & Developmental Biology, 27, 118-127. [More Information]

2013

  • Wu, J., Breen, E., Song, X., Cooke, B., Molloy, M. (2013). A protein annotation framework empowered with semantic reasoning. 12th International Semantic Web Conference, ISWC 2013, Australia: CEUR-WS.
  • Pascovici, D., Gardiner, D., Song, X., Breen, E., Solomon, P., Keighley, T., Molloy, M. (2013). Coverage and consistency: Bioinformatics aspects of the analysis of multirun iTRAQ experiments with wheat leaves. Journal of Proteome Research, 12(11), 4870-4881. [More Information]
  • Martinez-Aguilar, J., Molloy, M. (2013). Label-free selected reaction monitoring enables multiplexed quantitation of S100 protein isoforms in cancer cells. Journal of Proteome Research, 12(8), 3679-3688. [More Information]

2012

  • Nicholson, J., Neelagandan, K., Huart, A., Ball, K., Molloy, M., Hupp, T. (2012). An iTRAQ Proteomics Screen Reveals the Effects of the MDM2 Binding Ligand Nutlin-3 on Cellular Proteostasis. Journal of Proteome Research, 11(11), 5464-5478. [More Information]
  • Jankova, L., Robertson, G., Chan, C., Tan, K., Kohonen-Corish, M., Fung, C., Clarke, C., Lin, B., Molloy, M., Chapuis, P., Bokey, E., Dent, O., Clarke, S. (2012). Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study. BMC Cancer, 12, 1-9. [More Information]
  • Krisp, C., McKay, M., Wolters, D., Molloy, M. (2012). Multidimensional protein identification technology-selected reaction monitoring improving detection and quantification for protein biomarker studies. Analytical Chemistry, 84(3), 1592-1600. [More Information]

2011

  • Fung, D., Lo, A., Jankova, L., Clarke, S., Molloy, M., Robertson, G., Wilkins, M. (2011). Classification of Cancer Patients Using Pathway Analysis and Network Clustering. In Gerard Cagney, Andrew Emili (Eds.), Network Biology: Methods and Applications, (pp. 311-336). New York: Humana Press.
  • Tan, K., Jankova, L., Chan, C., Fung, C., Clarke, C., Lin, B., Robertson, G., Molloy, M., Chapuis, P., Bokey, E., Clarke, S., et al (2011). Clinicopathological correlates and prognostic significance of glutathione S-transferase Pi expression in 468 patients after potentially curative resection of node-positive colonic cancer. Histopathology, 59(6), 1057-1070. [More Information]
  • Yang, J., MacDougall, M., McDowell, M., Xi, L., Wei, R., Zavadoski, W., Molloy, M., Baker, J., Kuhn, M., Cabrera, O., et al (2011). Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes. BMC Genomics, 12, 1-14. [More Information]

2010

  • Fung, C., Chan, C., Jankova, L., Dent, O., Robertson, G., Molloy, M., Bokey, E., Chapuis, P., Lin, B., Clarke, S. (2010). Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer. Histopathology, 56(3), 319-330. [More Information]
  • Lam, F., Jankova, L., Dent, O., Molloy, M., Kwun, S., Clarke, C., Chapuis, P., Robertson, G., Beale, P., Clarke, S., Bokey, E., Chan, C. (2010). Identification of distinctive protein expression patterns in colorectal adenoma. Proteomics - Clinical Applications, 4(1), 60-70. [More Information]

2009

  • Zhao, L., Lee, B., Brown, D., Molloy, M., Marx, G., Pavlakis, N., Boyer, M., Stockler, M., Kaplan, W., Breit, S., et al (2009). Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling. Cancer Research, 69(19), 7696-7703. [More Information]

2007

  • McKay, M., Sherman, J., Laver, M., Baker, M., Clarke, S., Molloy, M. (2007). The development of multiple reaction monitoring assays for liver-derived plasma proteins. Proteomics - Clinical Applications, 1(12), 1570-1581. [More Information]

Selected Grants

2025

  • Preventing Bowel Cancers with Novel Molecular Tests, Molloy M, Tour de Cure Ltd/Research Matching Grant

2023

  • Rewarding Research 2024, Molloy M, Faculty of Medicine and Health/FMH Rewarding Research Success
  • Externally funded position-Julius Woongki Kim, Molloy M, Northern Sydney Local Health District (NSLHD)/Externally Funded Position
  • IVIS Lumina Series-III In Vivo Imaging System, Molloy M, DVC Research/Equipment Grant
  • Improving outcomes for patients with colorectal liver metastases, Molloy M, Hughes T, Wong G, Tour de Cure Ltd/Research Matching Grant